Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1842 1
1930 1
1931 1
1932 1
1933 2
1934 1
1938 1
1945 1
1946 5
1947 7
1948 5
1949 5
1950 6
1951 3
1952 3
1953 3
1954 3
1955 6
1956 6
1957 8
1958 8
1959 6
1960 5
1961 5
1962 6
1963 7
1964 7
1965 10
1966 3
1967 7
1968 2
1969 4
1970 6
1971 8
1972 5
1973 7
1974 4
1975 6
1976 7
1977 7
1978 13
1979 9
1980 10
1981 11
1982 13
1983 15
1984 14
1985 17
1986 11
1987 17
1988 14
1989 26
1990 25
1991 20
1992 12
1993 24
1994 27
1995 23
1996 18
1997 23
1998 29
1999 27
2000 21
2001 31
2002 31
2003 47
2004 58
2005 58
2006 62
2007 78
2008 63
2009 54
2010 57
2011 63
2012 67
2013 61
2014 46
2015 55
2016 64
2017 63
2018 53
2019 70
2020 67
2021 80
2022 62
2023 46
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

1,856 results

Results by year

Filters applied: . Clear all
Page 1
Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial.
Shohdy KS, Pillai M, Abbas KS, Allison J, Waddell T, Darlington E, Mohammad S, Hood S, Atkinson S, Simpson K, Morgan D, Nathan P, Kilgour E, Dive C, Thistlethwaite F. Shohdy KS, et al. Among authors: allison j. Immunooncol Technol. 2024 Mar 18;22:100712. doi: 10.1016/j.iotech.2024.100712. eCollection 2024 Jun. Immunooncol Technol. 2024. PMID: 38694705 Free PMC article.
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer.
Aparicio AM, Tidwell RSS, Yadav SS, Chen JS, Zhang M, Liu J, Guo S, Pilie PG, Yu Y, Song X, Vundavilli H, Jindal S, Zhu K, Viscuse PV, Lebenthal JM, Hahn AW, Soundararajan R, Corn PG, Zurita AJ, Subudhi SK, Zhang J, Wang W, Huff C, Troncoso P, Allison JP, Sharma P, Logothetis CJ. Aparicio AM, et al. Among authors: allison jp. Clin Cancer Res. 2024 Apr 29. doi: 10.1158/1078-0432.CCR-23-3740. Online ahead of print. Clin Cancer Res. 2024. PMID: 38683200
Peer Texting to Promote Quitline Use and Smoking Cessation Among Rural Participants in Vietnam: Randomized Clinical Trial.
Sadasivam RS, Nagawa CS, Wijesundara JG, Flahive J, Nguyen HL, Larkin C, Faro JM, Balakrishnan K, Ha DA, Nguyen CK, Vuong A, Phan PT, Pham QPL, Allison JJ, Houston TK. Sadasivam RS, et al. Among authors: allison jj. Int J Public Health. 2024 Apr 8;69:1606941. doi: 10.3389/ijph.2024.1606941. eCollection 2024. Int J Public Health. 2024. PMID: 38651035 Free PMC article. Clinical Trial.
Comparing pulsed field electroporation and radiofrequency ablation for the treatment of paroxysmal atrial fibrillation: design and rationale of the BEAT PAROX-AF randomized clinical trial.
Erhard N, Frison E, Asselineau J, Aouar B, Boveda S, Cochet H, Deisenhofer I, Deneke T, Gimbert A, Kautzner J, Knecht S, Maury P, Neuzil P, Rousset M, Scherr D, Schneider CW, Sermesant M, Wichterle D, Jaïs P; BEAT-AF Study group. Erhard N, et al. Europace. 2024 May 2;26(5):euae103. doi: 10.1093/europace/euae103. Europace. 2024. PMID: 38646926 Free PMC article.
1,856 results